Leica Biosystems completes StatLab deal to boost cancer diagnostics
Leica Biosystems has wrapped up its purchase of StatLab Medical Products, aiming to speed up and sharpen cancer diagnosis for labs and patients.
Danaher Corporation 1 article
The biotechnology profile of Danaher Corporation is defined by Danaher life sciences and diagnostics and life science instrumentation portfolio, placing it as a diversified life-science and diagnostics technology corporation. The underlying stack extends from bioprocessing technologies to molecular diagnostics platforms, with laboratory automation businesses distinguishing its business role from a single assay or software package. The scope is company-level: individual products, instruments and methods connected with the business are mapped independently from Danaher Corporation.